Pioneering the Future of Immunoengineering
Welcome to the Center for Immunoengineering (IE) at Georgia Tech. The IE Center envisions a future where the fusion of engineering and immunology transforms the landscape of human health, targeting critical disease areas: cancer, aging, infectious diseases, autoimmune disorders, and inflammation. We bring together engineers, biologists, clinicians, and industry leaders to deliver innovative solutions that address these global challenges. Our mission is to lead the charge in personalized and predictive healthcare, leveraging state-of-the-art technology and translational research to create therapies that are more effective, less invasive, and widely accessible. This bold vision establishes the IE Center as a beacon of hope and progress to sustain and amplify its life-changing work.
The Center for Immunoengineering at Georgia Tech is founded on a deep commitment to translational research and the Center is focused on delivering real-world impact in areas including:
- Infectious disease, autoimmune and inflammatory disorders: We foresee a world where rapid immuno-profiling and precise immune modulation outpace emerging pathogens, delivering scalable therapies and robust defenses against pandemics.
- Clinical transplantation and regenerative medicine: We envision making transplants and tissue repair safer and more successful. By using smart materials, we’re tweaking the area where a transplant occurs so the body accepts it better without needing heavy, long-term drugs that weaken the immune system. We are also using stem cells for more effective transplants and to even regrow damaged tissues. This could bring new hope to millions of people waiting for life-changing treatments.
- Cancer immunoengineering: We aim to revolutionize treatment by engineering advanced biomaterials and human model systems that mimic tumor microenvironments, enabling the development of next-generation therapies with unparalleled specificity.
- Aging and immune resilience: Our vision lies in decoding the immune system’s decline over time, using predictive modeling and organoid platforms to design interventions that restore vitality and combat age-related diseases.
